IBEX Limited
NASDAQ:IBEXInformation Technology Services
-$0.52 today
- Market cap
- $740.03M
- Beta
- 0.70
- P/E (TTM)
- 8.5
- EPS (TTM)
- $3.51
Volume 0.14M
Average 0.12M
IBEX EBITDA Margin
EBITDA as a percentage of revenue.
IBEX LimitedNASDAQ: IBEX
EBITDA Margin · Q3 FY2026 · quarter ended Mar 2026
EBITDA Margin holds steady near 13.0%
EBITDA Margin was 13.0% in Q3 FY2026, up 0.4 pp from a year earlier. On a trailing-twelve-month basis it was 12.1%, down 0.2 pp year over year. Over 3 fiscal years it widened by 3.7 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 12.6% for the fiscal year ending Jun 2026, up from 11.6% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 13.0%+0.8 pp QoQ
- Last fiscal yearJun 2025
- 11.6%-0.4 pp YoY
- LTMMar 2026
- 12.1%-0.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.4 pp | +1.7 pp | +1.3 pp |
| 1 year | -0.4 pp | +1.0 pp | +1.4 pp |
| 3 years | +3.7 pp | +1.2 pp | -2.6 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 11.6%
- Year-over-year change
- -0.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 11.6% | -0.4pp |
| FY2024 | 2024-06-30 | 12.0% | +0.5pp |
| FY2023 | 2023-06-30 | 11.5% | +3.6pp |
| FY2022 | 2022-06-30 | 7.9% | -0.8pp |
| FY2021 | 2021-06-30 | 8.6% | — |
EBITDA Margin vs competitors
How IBEX compares with its peers on the latest reported figures
- IBEX's LTM Mar 2026 EBITDA Margin of 12.1% is the highest of the 4 companies compared; the peer median is -1.1%.
- Its year-over-year change of -0.2 pp is the 3rd highest of 4, against a peer median of +1.1 pp.
- Over three fiscal years its change of +3.7 pp compares with a peer median of -12.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 12.1% | -0.2 pp | +3.7 pp | |
| LTM Mar 2026 | 4.0% | +2.4 pp | -2.2 pp | |
| LTM Mar 2026 | -1.1% | +1.1 pp | -12.7 pp | |
| LTM Feb 2026 | -3.1% | -16.9 pp | -18.0 pp | |
| Peer median (excluding IBEX) | -1.1% | +1.1 pp | -12.7 pp | |
Competitors are the stored peer set for IBEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 443.39M | 492.85M | 523.12M | 508.57M | 558.27M |
| Cost of Revenue | 335.25M | 373.97M | 374.99M | 356.54M | 385.69M |
| Gross Profit | 108.14M | 118.88M | 148.13M | 152.03M | 172.58M |
| Gross Margin | 24.4% | 24.1% | 28.3% | 29.9% | 30.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 80.15M | 88.66M | 93.14M | 108.74M |
| Operating Expenses | 91.09M | 98.25M | 107.65M | 112.6M | 125.97M |
| Depreciation & Amortization | 14.12M | 18.1M | 18.99M | 19.46M | 17.23M |
| EBITDA | 38.31M | 38.77M | 60.1M | 60.96M | 64.8M |
| EBITDA Margin | 8.6% | 7.9% | 11.5% | 12.0% | 11.6% |
| Operating Income | 17.05M | 20.63M | 40.48M | 39.43M | 46.61M |
| Operating Margin | 3.8% | 4.2% | 7.7% | 7.8% | 8.3% |
| Interest Income | 0 | 43K | 640K | 2.07M | 955K |
| Interest Expense | 9.03M | 1.29M | 792K | 514K | 1.63M |
| Other Income / Expenses | (1.89M) | (1.25M) | (152K) | 1.56M | (679K) |
| Income Before Tax | 15.15M | 19.38M | 40.33M | 40.99M | 45.93M |
| Pre-Tax Margin | 3.4% | 3.9% | 7.7% | 8.1% | 8.2% |
| Income Tax Expense | 2.06M | (2.08M) | 8.74M | 7.33M | 9.07M |
| Net Income | 13.09M | 21.46M | 31.58M | 33.66M | 36.86M |
| Net Margin | 3.0% | 4.4% | 6.0% | 6.6% | 6.6% |
| EPS (Basic) | 0.16 | 1.18 | 1.74 | 1.90 | 2.51 |
| EPS (Diluted) | 0.15 | 1.15 | 1.67 | 1.84 | 2.36 |
| Weighted Avg Shares | 17.65M | 18.23M | 18.2M | 17.7M | 14.68M |
| Weighted Avg Shares (Diluted) | 18.38M | 18.72M | 18.89M | 18.26M | 15.73M |
IBEX Limited
NASDAQ:IBEX
Intrinsic Alpha fair value
Locked
Current Price
$55.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.